Makoto Nakamuta - Concepedia

Author

Makoto Nakamuta

Also Known As

Enjoji, Grace Wong, Hiroshi Yatsuhashi, Ken Shirabe, M NAKAMUTA, M Nakamuta, M. Nakamuta, MAKOTO NAKAMUTA, Makoto Chuma, Makoto NAKAMUTA

356

Publications

10.5K

Citations

H-Index

159

Concepts

All Affiliations

Kyushu University National Kyushu Medical Center Fukuoka University Kyushu University Hospital Fukuoka City Hospital

About

Makoto Nakamuta is an author at Kyushu University specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	69	4.5K
2	Health Sciences	18	21	2.4K
3	Natural Sciences	4	4	171
4	Public Health	3	3	97
5	Language Studies	1	1	27

Makoto Nakamuta

167

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease Motoyuki Kohjima, Munechika Enjoji, Nobito Higuchi, International Journal of Molecular Medicine PathologyFatty Liver DiseaseMetabolic SyndromeMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver Disease	2007	525
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial Josep M. Llovet, Masatoshi Kudo, Philippe Merle, The Lancet Oncology OncologyHepatologyMedicineClinical TrialsPembrolizumab Versus Lenvatinib	2023	364
SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease Motoyuki Kohjima, Nobito Higuchi, Masaki Kato, International Journal of Molecular Medicine Fatty Liver DiseaseInsulin SignalingObesityMetabolic SyndromeNonalcoholic Fatty Liver Disease	2008	362
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, Journal of Gastroenterology Metabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseLiver Physiology	2015	326
Liver X receptor in cooperation with SREBP‐1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease Nobito Higuchi, Masaki Kato, Yuki Shundo, Hepatology Research	2008	280
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population Minoru Nakamura, Nao Nishida, Minae Kawashima, The American Journal of Human Genetics Genome-wide Association StudyHepatologyLiver PhysiologyGeneticsGenetic Epidemiology	2012	269
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol Kenichiro Yasutake, Makoto Nakamuta, Yuki Shima, Scandinavian Journal of Gastroenterology	2008	216
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, Hepatology Research	2015	204
Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid Akira Honda, Tadashi Ikegami, Makoto Nakamuta, Hepatology	2012	199
Reversal of Hypercholesterolemia in Low Density Lipoprotein Receptor Knockout Mice by Adenovirus-mediated Gene Transfer of the Very Low Density Lipoprotein Receptor Kunihisa Kobayashi, Kazuhiro Oka, Trudy M. Forte, Journal of Biological Chemistry	1996	129

Page 1